Physical Therapists in West Newton, PA Accepting Medicare
4 Physical Therapists found. Showing 1 - 4
 Dr. Jennifer Jo Kostik Johnson, DPT, ATC Physical Therapist Medicare: Medicare Enrolled Practice Location: 112 Walnut Ln, Suite 10, West Newton, PA 15089 Phone: 724-872-0356 Fax: 724-872-6051 |
Kelsey Stottlemyer Pust, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Greensburg Pike, West Newton, PA 15089 Phone: 724-872-0356 Fax: 724-872-6051 |
Emily E Bell, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Greensburg Pike, #2, West Newton, PA 15089 Phone: 724-872-0356 Fax: 724-872-6051 |
 Douglas Bandurak, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Greensburg Pike, West Newton, PA 15089 Phone: 724-872-0356 Fax: 724-872-6051 |
News Archive
Study proposes potential molecular mechanism at play in mild TBI
Douglas Smith, MD, director of the Center for Brain Injury and Repair and professor of Neurosurgery at the University of Pennsylvania School of Medicine, will present information on the molecular mechanism at play in mild TBI (mTBI), commonly called concussions. Although mTBI affects over 1 million people each year in the United States, it is generally ignored as a major health issue. However, this 'mild' form of injury induces persisting neurological and cognitive problems in many of these patients, exacting an enormous emotional and financial toll on society.
NeuroSigma, VA partner to evaluate eTNS system for TBI patients in Phase I clinical trial
NeuroSigma, Inc., a California-based life sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Veterans Affairs for a clinical trial to evaluate the benefits of non-invasive, external Trigeminal Nerve Stimulation (eTNS) for patients with traumatic brain injury (TBI) in a Phase I clinical trial.
TSRI researchers find interferon beta protein as prime suspect in persistent viral infections
Interferon proteins are normally considered virus-fighters, but scientists at The Scripps Research Institute have found evidence that one of them, interferon beta (IFNβ), has an immune-suppressing effect that can help some viruses establish persistent infections.
IsoFlow Infusion catheter allows physicians to increase drug concentrations at targeted sites
Vascular Designs, a medical device company, today announced that its IsoFlow(TM) infusion catheter has secured 510(k) marketing clearance by the U.S. Food and Drug Administration (FDA) for the direct delivery of medications into highly targeted areas. An important application of IsoFlow may be in the treatment of cancer.
Atmospheric oxygen may play role in lung carcinogenesis, new study suggests
The ancient physician/alchemist, Paracelsus, said: "The dose makes the poison." According to a new study published in PeerJ, even oxygen may fall prey to the above adage. While essential to human life, aspects of oxygen metabolism may promote cancer. Capitalizing on the inverse relationship of oxygen concentration with elevation, researchers found lower rates of lung cancer at higher elevations, a trend that did not extend to non-respiratory cancers, suggesting that carcinogen exposure occurs via inhalation.
› Verified 6 days ago